Suchergebnisse - "Ariceta, Beñat"

PubPharm (10)

1

Single cell profiling of del(5q) MDS unveils its transcriptional landscape and the impact of lenalidomide

enthalten in: bioRxiv.org | 2023

von Serrano, G. | Berastegui, N. | Díaz-Mazkiaran, A. | +22

2

Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

enthalten in: British journal of haematology | 2023

von Simoes, C. | Villar, S. | Ariceta, B. | +32

3

Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemia

enthalten in: JCI insight | 2023

von Stölzel, F. | Fordham, S. | Nandana, D. | +41

4

Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia

enthalten in: Blood advances | 2023

von Simoes, C. | Chillon, M. | Martínez-Cuadrón, D. | +28

5

Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

enthalten in: British Journal of Haematology | 2023

von Simoes, C. | Villar, S. | Ariceta, B. | +31

6

The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients

enthalten in: Frontiers in oncology | 2022

von Villar, S. | Ariceta, B. | Agirre, X. | +18

7

Biallelic TET2 mutation sensitizes to 5’-azacitidine in acute myeloid leukemia

enthalten in: bioRxiv.org | 2021

von Stölzel, F. | Fordham, S. | Lin, W. | +35

8

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms

enthalten in: Journal of clinical medicine | 2020

von Aguirre-Ruiz, P. | Ariceta, B. | Viguria, M. | +14

9

Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data

enthalten in: Leukemia research | 2020

von Aguilera-Diaz, A. | Larrayoz, M. | Palomino-Echeverría, S. | +12

CommentIn: Leuk Res. 2020 Sep;96:106431. - PMID 32771235

10

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design

enthalten in: PloS one | 2020

von Aguilera-Diaz, A. | Vazquez, I. | Ariceta, B. | +11

1
[1]